Difference between revisions of "Wang T, et al. Cancer Lett. (2018) cited as Ref 152 in DOI: 10.1038/s41392-020-0110-5 (Q9415)"
Jump to navigation
Jump to search
(Created a new Item: #quickstatements; #temporary_batch_1589975872009) |
(Created claim: Page(s) (P105): 11-24, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
(8 intermediate revisions by the same user not shown) | |||||||||||||||
Property / First Author string | |||||||||||||||
+ | Wang T | ||||||||||||||
Property / First Author string: Wang T / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / DOI Identifier | |||||||||||||||
+ | |||||||||||||||
Property / DOI Identifier: 10.1016/j.canlet.2018.05.003 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / PubMed ID | |||||||||||||||
+ | |||||||||||||||
Property / PubMed ID: 29746925 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Publication Date | |||||||||||||||
+ | 2018
| ||||||||||||||
Property / Publication Date: 2018 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Published In Name String | |||||||||||||||
+ | Cancer Lett. | ||||||||||||||
Property / Published In Name String: Cancer Lett. / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Volume | |||||||||||||||
+ | 430 | ||||||||||||||
Property / Volume: 430 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / title | |||||||||||||||
+ | SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance (English) | ||||||||||||||
Property / title: SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance (English) / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Page(s) | |||||||||||||||
+ | 11-24 | ||||||||||||||
Property / Page(s): 11-24 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
links / sliswiki / name | links / sliswiki / name | ||||||||||||||
+ |
Latest revision as of 15:32, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Wang T, et al. Cancer Lett. (2018) cited as Ref 152 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Wang T
0 references
2018
0 references
Cancer Lett.
0 references
430
0 references
SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance (English)
0 references
11-24
0 references